Concepedia

Hedy Teppler

HT

56

Publications

6.8K

Citations

33

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Rockefeller University

Harvard University

University of Bonn

Hedy Teppler is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, hiv, and pharmacotherapy.

Top concepts

Publications per year

1992–2023

56

Publications

56

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 917 citations · Full text

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar et al. · New England Journal of Medicine · 2008 · 683 citations · Full text

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

David A. Cooper, Roy T. Steigbigel, José M. Gatell et al. · New England Journal of Medicine · 2008 · 505 citations · Full text

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

S. Park, Rosemarie Kelly, Jennifer Nielsen Kahn et al. · Antimicrobial Agents and Chemotherapy · 2005 · 426 citations · Full text

, , +22

Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

Martin Markowitz, Bach‐Yen Nguyen, Eduardo Gotuzzo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 407 citations

Rows per page

1–5 of 56